NEU neuren pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-14

  1. 3,030 Posts.
    lightbulb Created with Sketch. 2810
    Agree, Teamlaunch. In a sense, Neuren has painted itself into a corner with the exclusivity deal. Failure to execute would not be pretty. Someone recently opined that Neuren would have the upper hand the nearer we come to the exclusivity period ending. I'm not sure about that: IMO Neuren is under equal pressure to get the job done. Both parties committed to best endeavors to reach a deal, but if both try to hold out we could end up with a Mexican stand-off and no cigar.

    I acknowledge the foundations have been laid for a deal - consolidation, board changes, exclusivity agreement - but crikey it's nail-biting stuff. No wonder I'm getting nervous and (probably unduly) pessimistic.

    OOO
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
-0.290(1.73%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.58 $16.74 $16.40 $9.107M 549.9K

Buyers (Bids)

No. Vol. Price($)
1 864 $16.43
 

Sellers (Offers)

Price($) Vol. No.
$16.50 1668 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.